Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Amortization of Deferred Charges (2023 - 2025)

Historic Amortization of Deferred Charges for Camp4 Therapeutics (CAMP) over the last 3 years, with Q3 2025 value amounting to $1000.0.

  • Camp4 Therapeutics' Amortization of Deferred Charges fell 9473.68% to $1000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $32000.0, marking a year-over-year decrease of 6734.69%. This contributed to the annual value of $83000.0 for FY2024, which is 978.26% down from last year.
  • According to the latest figures from Q3 2025, Camp4 Therapeutics' Amortization of Deferred Charges is $1000.0, which was down 9473.68% from -$95000.0 recorded in Q2 2025.
  • Camp4 Therapeutics' 5-year Amortization of Deferred Charges high stood at $111000.0 for Q1 2025, and its period low was -$95000.0 during Q2 2025.
  • Its 3-year average for Amortization of Deferred Charges is $16250.0, with a median of $20500.0 in 2024.
  • Within the past 5 years, the most significant YoY rise in Camp4 Therapeutics' Amortization of Deferred Charges was 31111.11% (2025), while the steepest drop was 53181.82% (2025).
  • Over the past 3 years, Camp4 Therapeutics' Amortization of Deferred Charges (Quarter) stood at $30000.0 in 2023, then tumbled by 50.0% to $15000.0 in 2024, then plummeted by 93.33% to $1000.0 in 2025.
  • Its last three reported values are $1000.0 in Q3 2025, -$95000.0 for Q2 2025, and $111000.0 during Q1 2025.